Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents.
D000230:Adenocarcinoma; D000284:Administration, Oral; D000818:Animals; D000962:Antimalarials / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D037621:Artemisinins / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D045744:Cell Line, Tumor; D019281:Dimerization; D004351:Drug Resistance; D004354:Drug Screening Assays, Antitumor; D005434:Flow Cytometry; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D010963:Plasmodium falciparum / Q000187:drug effects; D011471:Prostatic Neoplasms; D013329:Structure-Activity Relationship
D000962:Antimalarials; D000970:Antineoplastic Agents; D037621:Artemisinins